article thumbnail

UC Berkeley researchers develop CT-based 'virtual stress test' for BMD

AuntMinnie

Preventive Services Task Force (USPSTF) is currently reviewing its 2018 guidance for osteoporosis screening, lead researcher Tony Keaveny, PhD, of Berkeley BioMechanics Laboratory, told AuntMinnie.com. Diagnostics. In 2018 O.N. Diagnostics plans to submit further clearance documents to the U.S. Physicians send O.N.

X-ray 105
article thumbnail

Lunit's AI-Powered Mammography Analysis Solution Achieves Comparable Diagnostic Performance with Human Readers

Imaging Technology

milla1cf Wed, 09/13/2023 - 15:56 September 13, 2023 — Lunit , a leading provider of AI- powered solutions for cancer diagnostics and therapeutics, has unveiled the results of a collaborative study with Dr. Yan Chen , Ph.D., Professor of digital screening at the University of Nottingham, United Kingdom.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

American Roentgen Ray Society Awards 2024 ARRS Gold Medal to Former President, Present Roentgen Fund Chair, Philip Costello

Imaging Technology

Gaveled in as ARRS President during the 2018 Annual Meeting in Washington, DC, presently, Dr. Costello chairs the six vital scholarship programs of ARRS’ own The Roentgen Fund—cementing dual foundations in innovation and leadership for a true diversity of radiology’s next generation.

Hospital 100
article thumbnail

Blue Earth Diagnostics Announces Addition of POSLUMA (Flotufolastat F 18) Injection to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer

Imaging Technology

POSLUMA is widely available through 36 radiopharmacies in the national network of Blue Earth Diagnostics’ commercial U.S. The addition of POSLUMA to the highly respected NCCN Guidelines is a major milestone for Blue Earth Diagnostics,” said David E. Chief Medical Officer of Blue Earth Diagnostics. Teoh, MBBS, MRCP, FRCR, D.Phil.,

Clinic 84
article thumbnail

U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

Imaging Technology

milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. Chief Executive Officer of Blue Earth Diagnostics. Gauden , D.Phil.,

article thumbnail

Nomogram combines ultrasound features to assess thyroid nodules

AuntMinnie

A method of integrating information from multiple ultrasound modalities should be developed to improve diagnostic accuracy as a further supplementary tool for the risk stratification performance of the current TI-RADS,” they wrote. The American College of Radiology (ACR) created TI-RADS based on gray-scale ultrasound features.

article thumbnail

FAPI-PET shows promise for detecting pancreatic cancer

AuntMinnie

FAPI-PET imaging may become a powerful diagnostic tool for detecting pancreatic cancer, according to a study published November 16 in the Journal of Nuclear Medicine. They found high detection rates and diagnostic accuracy, as well as superior performance to standard imaging.